Literature DB >> 11423757

Remission achieved in chronic nephropathy by a multidrug approach targeted at urinary protein excretion.

P Ruggenenti1, B M Brenner, G Remuzzi.   

Abstract

Regardless of the pattern of renal involvement, increased urinary protein excretion rate is the best independent predictor of progression of chronic nephropathies and short-term reduction in proteinuria has been reported to be renoprotective in the long term. Despite such evidence, however, the therapeutic target in renoprotection is almost exclusively on blood pressure control. We report the clinical course of a patient with chronic nephropathy after the institution of a multidrug treatment titrated against urinary protein excretion to achieve renoprotection. The present findings indicate that adjusting renoprotective therapy according to the decline in protein excretion in a multidrug strategy may stabilize or even reverse renal disease progression. This approach should be formally explored in prospective studies. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423757     DOI: 10.1159/000045998

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  10 in total

1.  Animal models of regression/progression of kidney disease.

Authors:  Beom Jin Lim; Hai-Chun Yang; Agnes B Fogo
Journal:  Drug Discov Today Dis Models       Date:  2014

Review 2.  Treatment of membranous nephropathy: time for a paradigm shift.

Authors:  Piero Ruggenenti; Fernando C Fervenza; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

3.  Achieving remission of proteinuria in childhood CKD.

Authors:  Piero Ruggenenti; Paolo Cravedi; Antonietta Chianca; MariaRosa Caruso; Giuseppe Remuzzi
Journal:  Pediatr Nephrol       Date:  2016-10-04       Impact factor: 3.714

Review 4.  Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.

Authors:  Giuseppe Remuzzi; Ariela Benigni; Andrea Remuzzi
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

5.  Risk factors for renal failure in children with non-glomerular nephropathies.

Authors:  Mieczysław Litwin
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

6.  Role of remission clinics in the longitudinal treatment of CKD.

Authors:  Piero Ruggenenti; Elena Perticucci; Paolo Cravedi; Vincenzo Gambara; Marco Costantini; Sanjib Kumar Sharma; Annalisa Perna; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 10.121

7.  Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition.

Authors:  Daniela Macconi; Fabio Sangalli; Maria Bonomelli; Sara Conti; Lucia Condorelli; Elena Gagliardini; Giuseppe Remuzzi; Andrea Remuzzi
Journal:  Am J Pathol       Date:  2009-01-22       Impact factor: 4.307

Review 8.  Clinical impact of renin-angiotensin system blockade: angiotensin-converting enzyme inhibitors vs. angiotensin receptor antagonists.

Authors:  Joseph L Izzo; Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

Review 9.  Does remission of renal disease associated with antihypertensive treatment exist?

Authors:  Paolo Cravedi; Piero Ruggenenti; Giuseppe Remuzzi
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

10.  Proteinuria as a Therapeutic Target in Advanced Chronic Kidney Disease: a Retrospective Multicenter Cohort Study.

Authors:  Chang-Hsu Chen; Hon-Yen Wu; Chieh-Li Wang; Feng-Jung Yang; Pei-Chen Wu; Szu-Chun Hung; Wei-Chih Kan; Chung-Wei Yang; Chih-Kang Chiang; Jenq-Wen Huang; Kuan-Yu Hung
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.